A panel of independent advisors to the FDA recommended Eli Lilly's Alzheimer's drug donanemab, paving the way for ...
Advisers to the FDA voted 11-0 to recommend the approval of a drug for early Alzheimer’s disease made by Eli Lilly.
Alzheimer’s is a devastating disease that affects millions of families, but there is hope on the horizon. A panel of FDA ...
A panel of federal health advisers is recommending that the U.S. Food and Drug Administration approve a new medication ...
WASHINGTON (AP) — A closely watched Alzheimer's drug from Eli Lilly won the backing of federal health advisers on Monday, ...
Eli Lilly filed even more lawsuits against med spas and wellness centers over unapproved versions of tirzepatide, the active ...
Here are important resources to help families dealing with Alzheimer's disease FDA panel backs new Alzheimer's drug ...
WASHINGTON — Senators on Wednesday blasted top health and law enforcement officials for not doing more to combat the rise of illegal electronic cigarettes in the U.S., a multibillion-dollar business ...
U.S. stock futures slipped lower Tuesday, amid caution ahead of the start of the latest Federal Reserve meeting.
COLUMBUS, Ohio (WCMH) — NBC4 Evening Anchor Colleen Marshall sat down for a brain cognition test, the same kind that will ...
The next six months for the FDA are primed to be as groundbreaking as the first six, with Eli Lilly’s donanemab and Lykos ...